Lykos CEO steps down, the latest move in a string of chaotic changes
Lykos Therapeutics CEO and founder Amy Emerson is stepping down, with Chief Operating Officer Michael Mullette taking over the top spot on an interim basis.
All Posts in "News Team"
Wall Street Gets Back to Climbing, and the Nasdaq Tops 20,000
Wall Street got back to climbing after the latest update on inflation appeared to clear the way for more help for the economy from the Federal Reserve
TikTok Files Challenge Against Canadian Government Order to Dissolve Its Business in the Country
TikTok has challenged a Canadian government order to shut down the Chinese video-sharing app’s business operations in the country that was imposed over national security concerns
Making a $1B Investment in the US? Trump Pledges Expedited Permits — but There Are Hurdles
President-elect Donald Trump is promising expedited federal permits for energy projects and other construction worth more than $1 billion
US Inflation Ticked up Last Month as Some Price Pressures Remain Persistent
Fueled by pricier used cars, hotel rooms and groceries, inflation in the United States moved slightly higher last month in the latest sign that some price pressures remain elevated
Astellas unveils Massachusetts lab that will be shared with biotechs, academia researchers
Astellas Pharma has cut the ribbon on a new life sciences center in Massachusetts that will house 400 team members and an incubator lab.
Over-the-counter CGM market grows, with Abbott’s Lingo debut
With the rollout of its new over-the-counter continuous glucose monitor, Abbott aims to help its customers speak the hidden language of their bodies’ response to food, exercise and stress.
Lilly closes distance on Novo with another clutch of positive data on once-weekly insulin prospect
On the heels of an FDA rejection for its chief rival Novo Nordisk, Eli Lilly is gaining ground in the race to bring a once-weekly insulin to the U.S.
Chlamydia may lurk unseen in intestines, requiring a new antibiotic approach
The bacterium Chlamydia trachomatis is best known for infecting genitals, causing the sexually transmitted infection (STI) known as chlamydia. But a new study has found that these sneaky cells can also infiltrate our guts, building a hidden supply of bacteria that could then leak to the genitals and cause reoccurring infections.
Novartis ignites new stage of Voyager pact with $15M capsid deal
Novartis is opening a new frontier in its collaboration with Voyager Therapeutics, paying $15 million to take up its option on a novel capsid for use in a rare neurological disease gene therapy program.
Jazz HER2 bispecific posts 59% survival at 30 months in gastric cancer
Pfizer sees weight gain in cancer patients, aims to enter phase 3 in 2025
‘Cooking with gas’: Regeneron sees its Opdualag rival as next big thing for treating solid tumors
IO Biotech’s vaccine and Keytruda combo hits primary endpoint in phase 2 squamous cell carcinoma trial
iTeos-GSK’s TIGIT combo shows 30% more tumor shrinkage than Jemperli, but safety signals scare investors
Eli Lilly sells Life Sciences Studio lab to Arctoris, moving automation platform from San Diego to Oxford
Biolexis enters oral GLP-1 horse race with preclinical study showing small molecule reduced weight of obese mice
AstraZeneca steps out from Daiichi’s shadow, posting data on ADC rivals to AbbVie, Pfizer
Wall Street Rises to Turn a Dismal Week Into Just a Bad One
Tesla Recalling Almost 700,000 Vehicles Due to Tire Pressure Monitoring System Issue